Structure and function of a custom anticancer peptide, CB1a

Peptides

Volumn 30, Issue 5, 2009, Pages 839-848

  Wu, Jiun Ming ^b,c   Jan, Pey Shynan ^a   Yu, Hui Chen ^a   Haung, Hsu Yuang ^a   Fang, Huey Jen ^b   Chang, Yuan I ^b   Cheng, Jya Wei ^c   Chen, Hueih Min ^a,b  

^a NATIONAL NANO DEVICE LABORATORIES   (Taiwan)

^b AGRICULTURAL BIOTECHNOLOGY RESEARCH CENTER   (Taiwan)

^c NATIONAL TSING HUA UNIVERSITY   (Taiwan)

Author keywords

Anticancer activity; Antimicrobial peptide; CD; Cecropin B; Heparin binding motif; ITC; NMR solution structure

Indexed keywords

ANTINEOPLASTIC AGENT; CECROPIN B 1A; LOW MOLECULAR WEIGHT HEPARIN; UNCLASSIFIED DRUG;

AMINO TERMINAL SEQUENCE; ARTICLE; CARBOXY TERMINAL SEQUENCE; CIRCULAR DICHROISM; DRUG STRUCTURE; HEMOLYSIS; HUMAN; IONIC STRENGTH; ISOTHERMAL TITRATION CALORIMETRY; LEUKEMIA; NUCLEAR MAGNETIC RESONANCE; PRIORITY JOURNAL; STOMACH CARCINOMA;

AMINO ACID SEQUENCE; ANIMALS; ANTINEOPLASTIC AGENTS; CALORIMETRY; CELL LINE; CELL LINE, TUMOR; CIRCULAR DICHROISM; FLOW CYTOMETRY; HEMOLYSIS; HUMANS; INSECT PROTEINS; MICROSCOPY, CONFOCAL; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; NUCLEAR MAGNETIC RESONANCE, BIOMOLECULAR; PROTEIN STRUCTURE, SECONDARY; STRUCTURE-ACTIVITY RELATIONSHIP;

HYALOPHORA CECROPIA;

EID: 67349094575     PISSN: 01969781     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.peptides.2009.02.004     Document Type: Article

References (60)

1. Andersson E., Rydengard V., Sonesson A., Morgelin M., Bjorck L., and Schmidtchen A. Antimicrobial activities of heparin-binding peptides. Eur J Biochem 271 (2004) 1219-1226
2. Andreu D., Merrifield R.B., Steiner H., and Boman H.G. N-terminal analogues of cecropin A: synthesis, antibacterial activity, and conformational properties. Biochemistry 24 (1985) 1683-1688
3. Baker M.A., Maloy W.L., Zasloff M., and Jacob L.S. Anticancer efficacy of Magainin2 and analogue peptides. Cancer Res 53 (1993) 3052-3057
4. Bax A., and Davis D.G. MLEV-17 based two-dimensional homonuclear magnetization transfer spectroscopy. J Magn Reson 65 (1985) 355
5. Bechinger B. Structure and functions of channel-forming peptides: magainins, cecropins, melittin and alamethicin. J Membr Biol 156 (1997) 197-211
6. Boman H.G., Wade D., Boman I.A., Wahlin B., and Merrifield R.B. Antibacterial and antimalarial properties of peptides that are cecropin-melittin hybrids. FEBS Lett 259 (1989) 103-106
7. Bucher P., and Bairoch A. A generalized profile syntax for biomolecular sequence motifs and its function in automatic sequence interpretation. Proc Int Conf Intell Syst Mol Biol 2 (1994) 53-61
8. Capila I., and Linhardt R.J. Heparin-protein interactions. Angew Chem Int Ed Engl 41 (2002) 391-412
9. Cardin A.D., and Weintraub H.J. Molecular modeling of protein-glycosaminoglycan interactions. Arteriosclerosis 9 (1989) 21-32
10. Chang D.K., Cheng S.F., Trivedi V.D., and Lin K.L. Proline affects oligomerization of a coiled coil by inducing a kink in a long helix. J Struct Biol 128 (1999) 270-279
11. Chen H.M., Clayton A.H., Wang W., and Sawyer W.H. Kinetics of membrane lysis by custom lytic peptides and peptide orientations in membrane. Eur J Biochem 268 (2001) 1659-1669
12. Chen H.M., Leung K.W., Thakur N.N., Tan A., and Jack R.W. Distinguishing between different pathways of bilayer disruption by the related antimicrobial peptides cecropin B, B1 and B3. Eur J Biochem 270 (2003) 911-920
13. Chen H.M., Wang W., Smith D., and Chan S.C. Effects of the anti-bacterial peptide cecropin B and its analogs, cecropins B-1 and B-2, on liposomes, bacteria, and cancer cells. Biochim Biophys Acta 1336 (1997) 171-179
14. Cruciani R.A., Barker J.L., Zasloff M., Chen H.C., and Colamonici O. Antibiotic magainins exert cytolytic activity against transformed cell lines through channel formation. Proc Natl Acad Sci USA 88 (1991) 3792-3796
15. Falquet L., Pagni M., Bucher P., Hulo N., Sigrist C.J., Hofmann K., et al. The PROSITE database, its status in 2002. Nucleic Acids Res 30 (2002) 235-238
16. Frohm M., Agerberth B., Ahangari G., Stahle-Backdahl M., Liden S., Wigzell H., et al. The expression of the gene coding for the antibacterial peptide LL-37 is induced in human keratinocytes during inflammatory disorders. J Biol Chem 272 (1997) 15258-15263
17. Fuchs S.M., and Raines R.T. Pathway for polyarginine entry into mammalian cells. Biochemistry 43 (2004) 2438-2444
18. Ghiselli R., Giacometti A., Cirioni O., Mocchegiani F., Orlando F., D'Amato G., et al. Cecropin B enhances betalactams activities in experimental rat models of gram-negative septic shock. Ann Surg 239 (2004) 251-256
19. Goncalves E., Kitas E., and Seelig J. Structural and thermodynamic aspects of the interaction between heparan sulfate and analogues of melittin. Biochemistry 45 (2006) 3086-3094
20. Hancock R.E. Cationic antimicrobial peptides: towards clinical applications. Expert Opin Investig Drugs 9 (2000) 1723-1729
21. Hancock R.E. Cationic peptides: effectors in innate immunity and novel antimicrobials. Lancet Infect Dis 1 (2001) 156-164
22. Hancock R.E., and Chapple D.S. Peptide antibiotics. Antimicrob Agents Chemother 43 (1999) 1317-1323
23. Hancock R.E., and Patrzykat A. Clinical development of cationic antimicrobial peptides: from natural to novel antibiotics. Curr Drug Targets Infect Disord 2 (2002) 79-83
24. Henriques S.T., Melo M.N., and Castanho M.A. Cell-penetrating peptides and antimicrobial peptides: how different are they?. Biochem J 399 (2006) 1-7
25. Hileman R.E., Fromm J.R., Weiler J.M., and Linhardt R.J. Glycosaminoglycan-protein interactions: definition of consensus sites in glycosaminoglycan binding proteins. Bioessays 20 (1998) 156-167
26. Holak T.A., Engstrom A., Kraulis P.J., Lindeberg G., Bennich H., Jones T.A., et al. The solution conformation of the antibacterial peptide cecropin A: a nuclear magnetic resonance and dynamical simulated annealing study. Biochemistry 27 (1988) 7620-7629
27. Hultmark D., Engstrom A., Bennich H., Kapur R., and Boman H.G. Insect immunity: isolation and structure of cecropin D and four minor antibacterial components from Cecropia pupae. Eur J Biochem 127 (1982) 207-217
28. Hultmark D., Steiner H., Rasmuson T., and Boman H.G. Insect immunity. Purification and properties of three inducible bactericidal proteins from hemolymph of immunized pupae of Hyalophora cecropia. Eur J Biochem 106 (1980) 7-16
29. Johansson J., Gudmundsson G.H., Rottenberg M.E., Berndt K.D., and Agerberth B. Conformation-dependent antibacterial activity of the naturally occurring human peptide LL-37. J Biol Chem 273 (1998) 3718-3724
30. Koradi R., Billeter M., and Wuthrich K. MOLMOL: a program for display and analysis of macromolecular structures. J Mol Graph 14 51-5 (1996) 29-32
31. Laskowski R.A., Rullmannn J.A., MacArthur M.W., Kaptein R., and Thornton J.M. AQUA and PROCHECK-NMR: programs for checking the quality of protein structures solved by NMR. J Biomol NMR 8 (1996) 477-486
32. Lehrer R.I., and Ganz T. Antimicrobial peptides in mammalian and insect host defence. Curr Opin Immunol 11 (1999) 23-27
33. Maloy W.L., and Kari U.P. Structure-activity studies on magainins and other host defense peptides. Biopolymers 37 (1995) 105-122
34. Marion D., and Wuthrich K. Application of phase sensitive two-dimensional correlated spectroscopy (COSY) for measurements of 1H-1H spin-spin coupling constants in proteins. Biochem Biophys Res Commun 113 (1983) 967-974
35. Ohsaki Y., Gazdar A.F., Chen H.C., and Johnson B.E. Antitumor activity of magainin analogues against human lung cancer cell lines. Cancer Res 52 (1992) 3534-3538
36. Oren Z., and Shai Y. Mode of action of linear amphipathic alpha-helical antimicrobial peptides. Biopolymers 47 (1998) 451-463
37. Papo N., and Shai Y. New lytic peptides based on the D,L-amphipathic helix motif preferentially kill tumor cells compared to normal cells. Biochemistry 42 (2003) 9346-9354
38. Papo N., and Shai Y. Host defense peptides as new weapons in cancer treatment. Cell Mol Life Sci 62 (2005) 784-790
39. Rance M., Sorensen O.W., Bodenhausen G., Wagner G., Ernst R.R., and Wuthrich K. Improved spectral resolution in cosy 1H NMR spectra of proteins via double quantum filtering. Biochem Biophys Res Commun 117 (1983) 479-485
40. Richard J.P., Melikov K., Vives E., Ramos C., Verbeure B., Gait M.J., et al. Cell-penetrating peptides. A reevaluation of the mechanism of cellular uptake. J Biol Chem 278 (2003) 585-590
41. Schiffer M., and Edmundson A.B. Use of helical wheels to represent the structures of proteins and to identify segments with helical potential. Biophys J 7 (1967) 121-135
42. Schwieters C.D., Kuszewski J.J., Tjandra N., and Clore G.M. The Xplor-NIH NMR molecular structure determination package. J Magn Reson 160 (2003) 65-73
43. Sharma S.V. Melittin resistance: a counterselection for ras transformation. Oncogene 7 (1992) 193-201
44. Sharma S.V. Melittin-induced hyperactivation of phospholipase A2 activity and calcium influx in ras-transformed cells. Oncogene 8 (1993) 939-947
45. Sigrist C.J., Cerutti L., Hulo N., Gattiker A., Falquet L., Pagni M., et al. PROSITE: a documented database using patterns and profiles as motif descriptors. Brief Bioinform 3 (2002) 265-274
46. Sipos D., Andersson M., and Ehrenberg A. The structure of the mammalian antibacterial peptide cecropin P1 in solution, determined by proton-NMR. Eur J Biochem 209 (1992) 163-169
47. Sreerama N., and Woody R.W. Estimation of protein secondary structure from circular dichroism spectra: comparison of CONTIN, SELCON, and CDSSTR methods with an expanded reference set. Anal Biochem 287 (2000) 252-260
48. Sreerama N., and Woody R.W. On the analysis of membrane protein circular dichroism spectra. Protein Sci 13 (2004) 100-112
49. Srisailam S., Arunkumar A.I., Wang W., Yu C., and Chen H.M. Conformational study of a custom antibacterial peptide cecropin B1: implications of the lytic activity. Biochim Biophys Acta 1479 (2000) 275-285
50. Srisailam S., Kumar T.K., Arunkumar A.I., Leung K.W., Yu C., and Chen H.M. Crumpled structure of the custom hydrophobic lytic peptide cecropin B3. Eur J Biochem 268 (2001) 4278-4284
51. Steiner H., Hultmark D., Engstrom A., Bennich H., and Boman H.G. Sequence and specificity of two antibacterial proteins involved in insect immunity. Nature 292 (1981) 246-248
52. Tieleman D.P., Shrivastava I.H., Ulmschneider M.R., and Sansom M.S. Proline-induced hinges in transmembrane helices: possible roles in ion channel gating. Proteins 44 (2001) 63-72
53. Tyagi M., Rusnati M., Presta M., and Giacca M. Internalization of HIV-1 tat requires cell surface heparan sulfate proteoglycans. J Biol Chem 276 (2001) 3254-3261
54. van Hofsten P., Faye I., Kockum K., Lee J.Y., Xanthopoulos K.G., Boman I.A., et al. Molecular cloning, cDNA sequencing, and chemical synthesis of cecropin B from Hyalophora cecropia. Proc Natl Acad Sci U S A 82 (1985) 2240-2243
55. Wang W., Smith D.K., and Chen H.M. The effect of pH on the structure, binding and model membrane lysis by cecropin B and analogs. Biochim Biophys Acta 1473 (1999) 418-430
56. Wang W., Smith D.K., Moulding K., and Chen H.M. The dependence of membrane permeability by the antibacterial peptide cecropin B and its analogs, CB-1 and CB-3, on liposomes of different composition. J Biol Chem 273 (1998) 27438-27448
57. Wiseman T., Williston S., Brandts J.F., and Lin L.N. Rapid measurement of binding constants and heats of binding using a new titration calorimeter. Anal Biochem 179 (1989) 131-137
58. Wishart D.S., and Sykes B.D. The 13C chemical-shift index: a simple method for the identification of protein secondary structure using 13C chemical-shift data. J Biomol NMR 4 (1994) 171-180
59. Zasloff M. Magainins, a class of antimicrobial peptides from Xenopus skin: isolation, characterization of two active forms, and partial cDNA sequence of a precursor. Proc Natl Acad Sci U S A 84 (1987) 5449-5453
60. Zasloff M. Antimicrobial peptides of multicellular organisms. Nature 415 (2002) 389-395